Management and Director Compensation	9 Months Ended
Sep. 30, 2026
Compensation Related Costs [Abstract]
Management and Director Compensation	Note 10 – Management and Director Compensation The Company paid its officers aggregate cash compensation of $433,460 and $788,322 for the three-month periods ended September 30, 2026 and 2025, respectively. For the nine-month periods ended September 30, 2026 and 2025, the Company paid its officers aggregate cash compensation of $1,420,801 and $2,316,641, respectively. Of the amounts paid through September 30, 2026, $472,000 was paid to Advanomics Corporation, a company controlled by the CEO of the Company. The Company paid its directors aggregate cash compensation of $100,000 for each of the three-month periods ended September 30, 2026 and 2025, and $300,000 for each of the nine-month periods ended September 30, 2026 and 2025. In April 2026, one of the directors of the Company received a stock award of 500 shares of common stock valued at $96,900. In August 2026, the same director received another stock award of 2,915 shares of common stock valued at $71,709.

The entire disclosure for compensation costs, including compensated absences accruals, compensated absences liability, deferred compensation arrangements and income statement compensation items. Deferred compensation arrangements may include a description of an arrangement with an individual employee, which is generally an employment contract between the entity and a selected officer or key employee containing a promise by the employer to pay certain amounts at designated future dates, usually including a period after retirement, upon compliance with stipulated requirements. This type of arrangement is distinguished from broader based employee benefit plans as it is usually tailored to the employee. Disclosure also typically includes the amount of related compensation expense recognized during the reporting period, the number of shares (units) issued during the period under such arrangements, and the carrying amount as of the balance sheet date of the related liability.

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Topic 710
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482969/710-10-50-1

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Topic 710
-Name Accounting Standards Codification
-Publisher FASB
-URI https://asc.fasb.org/710/tableOfContent

Name:	us-gaap_CompensationRelatedCostsGeneralTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration